Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Age-based ivermectin dosing safe, efficacious in children with scabies infection

In the treatment of scabies infection in children up to 2 years of age, age-based ivermectin dosing yields high response rates and is well-tolerated, according to the open-label phase 2 ITCHY 2 study.

Age-based ivermectin dosing safe, efficacious in children with scabies infection

22 giờ trước

Nivolumab-relatlimab safer than ipilimumab-nivolumab in advanced cutaneous melanoma

23 giờ trước

Treatment with nivolumab plus relatlimab results in a lower incidence of severe immune-related adverse events (irAEs), delayed onset of irAEs, and reduced rate of treatment discontinuation among patients with advanced cutaneous melanoma when compared with ipilimumab plus nivolumab, reports a study.

Nivolumab-relatlimab safer than ipilimumab-nivolumab in advanced cutaneous melanoma

23 giờ trước

Is spironolactone combined with low-dose minoxidil safe for hair loss in women?

19 Jun 2026

Combination therapy with oral spironolactone and low-dose oral minoxidil appears safe and tolerable among adult females with hair loss, reports a study. However, those using one or more blood pressure (BP)-altering medications are at increased risk of hypotension-related symptoms.

Is spironolactone combined with low-dose minoxidil safe for hair loss in women?

19 Jun 2026

Switching between JAK inhibitors a feasible solution for severe alopecia areata

18 Jun 2026

Patients with treatment-refractory alopecia areata (AA) may benefit from switching between Janus kinase inhibitors (JAKis), suggests a study.

Switching between JAK inhibitors a feasible solution for severe alopecia areata

18 Jun 2026

Trẻ sinh ra trong đại dịch có nguy cơ mắc các bệnh lý liên quan đến bệnh dị ứng do cơ địa cao hơn 46%

10 Jun 2026

Tỷ lệ mắc các bệnh dị ứng cơ địa ở trẻ nhỏ sinh tại Hồng Kông đã tăng 46% trong đại dịch COVID-19, có thể liên quan đến sự thay đổi của hệ vi sinh đường ruột ở trẻ sơ sinh do việc khử trùng mạnh mẽ. SIM03 và SIM05, các công thức sữa chứa lợi khuẩn được phát triển với sự hỗ trợ của trí tuệ nhân tạo (AI), đã chứng minh làm giảm mức độ nặng của chàm và cải thiện chất lượng sống (QoL) ở trẻ em và người lớn, bằng cách điều hòa hệ vi sinh đường ruột.

Trẻ sinh ra trong đại dịch có nguy cơ mắc các bệnh lý liên quan đến bệnh dị ứng do cơ địa cao hơn 46%

10 Jun 2026

$Lutikizumab shows promise in refractory hidradenitis suppurativa$

Lutikizumab shows promise in refractory hidradenitis suppurativa

10 Jun 2026

Treatment with lutikizumab appears to improve outcomes in patients with moderate-to-severe hidradenitis suppurativa (HS) who have not responded to anti-TNF therapy, according to a phase II trial.

Lutikizumab shows promise in refractory hidradenitis suppurativa

10 Jun 2026

Dupilumab improves AD symptoms in adult Asians

06 Jun 2026 bởi

Treatment with dupilumab results in significant improvements in the signs and symptoms of moderate-to-severe atopic dermatitis (AD) in adult Asian patients without any serious adverse effects, a Singapore study has shown.

Dupilumab improves AD symptoms in adult Asians

06 Jun 2026

Isotretinoin use in adolescence does not compromise linear growth

30 May 2026

Treatment with isotretinoin for acne in adolescents does not appear to exert a negative effect on adult height, as reported in a study.

Isotretinoin use in adolescence does not compromise linear growth

30 May 2026

Ixekizumab plus tirzepatide confers multiple benefits in patients with psoriasis, high BMI

27 May 2026 bởi

Taking ixekizumab and tirzepatide together results in higher rates of skin clearance and weight loss compared with ixekizumab alone in patients with psoriasis and overweight or obesity, who represent a population that is difficult to treat, according to the phase IIIb TOGETHER-PsO trial.

Ixekizumab plus tirzepatide confers multiple benefits in patients with psoriasis, high BMI

27 May 2026

Are tests necessary for psoriasis patients treated with biologics?

25 May 2026

Many routine baseline screening and monitoring tests show no clear benefit to psoriasis patients prescribed biologic treatments, according to a study.

Are tests necessary for psoriasis patients treated with biologics?

25 May 2026

Tin tức & Cập nhật

Xem bài viết Da liễu

Xem

Chuyên ngành:

Age-based ivermectin dosing safe, efficacious in children with scabies infection

Age-based ivermectin dosing safe, efficacious in children with scabies infection

Nivolumab-relatlimab safer than ipilimumab-nivolumab in advanced cutaneous melanoma

Nivolumab-relatlimab safer than ipilimumab-nivolumab in advanced cutaneous melanoma

Is spironolactone combined with low-dose minoxidil safe for hair loss in women?

Is spironolactone combined with low-dose minoxidil safe for hair loss in women?

Switching between JAK inhibitors a feasible solution for severe alopecia areata

Switching between JAK inhibitors a feasible solution for severe alopecia areata

Trẻ sinh ra trong đại dịch có nguy cơ mắc các bệnh lý liên quan đến bệnh dị ứng do cơ địa cao hơn 46%

Trẻ sinh ra trong đại dịch có nguy cơ mắc các bệnh lý liên quan đến bệnh dị ứng do cơ địa cao hơn 46%

Lutikizumab shows promise in refractory hidradenitis suppurativa

Lutikizumab shows promise in refractory hidradenitis suppurativa

Dupilumab improves AD symptoms in adult Asians

Dupilumab improves AD symptoms in adult Asians

Isotretinoin use in adolescence does not compromise linear growth

Isotretinoin use in adolescence does not compromise linear growth

Ixekizumab plus tirzepatide confers multiple benefits in patients with psoriasis, high BMI

Ixekizumab plus tirzepatide confers multiple benefits in patients with psoriasis, high BMI

Are tests necessary for psoriasis patients treated with biologics?

Are tests necessary for psoriasis patients treated with biologics?